Abstract
Background: O 6-Methylguanine-DNA methyltransferase MGMT is an enzyme that repairs O 6-methylguanine, a promutagenic DNA base damaged by endogenous and environmental alkylating agents. There are few reports that describe whether or not abnormal MGMT expression correlates with the prognosis in human solid cancers.
Methods: The expression of MGMT was immunohistochemically evaluated in 60, 62, 105, and 46 paraffin-embedded samples from patients with curatively resected hepatocellular, gastric, colorectal, and breast cancers, respectively.
Results: The expression of MGMT was a positive predictive factor for overall survival in hepatocellular P = .005 and gastric cancers P < .001 and for relapse-free survival in breast cancers P < .001. MGMT-positive gastric tumors n = 42 were correlated with the absence of serosal invasion P = .045, lymph node metastasis P = .006, intestinal type P = .018, and low pathological tumor, node, metastasis stage P < .001. All breast tumors that recurred locally after operation were MGMT negative P = .004. The clinicopathologic characteristics of colorectal cancers with respect to MGMT expression did not significantly differ.
Conclusions: The expression of MGMT is a predictive prognostic marker in patients with hepatocellular, gastric, and breast cancers. These findings may help to establish therapeutic strategies for patients with these types of solid cancer.
Article PDF
Similar content being viewed by others
References
Gerson SL, Trey JE, Miller K, Berger NA. Comparison of O6-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human, rat and mouse tissue. Carcinogenesis 1986; 7: 745–9.
Wani G, Wani AA, D’Ambrosio SM. Cell type-specific expression of the O6-alkylguanine-DNA alkyltransferase gene in normal human liver tissue as revealed by in situ hybridization. Carcinogenesis 1993; 14: 737–41.
Ito T, Nakamura T, Maki H, Sekiguchi M. Roles of transcription and repair in alkylation mutagenesis. Mutat Res 1994; 314: 273–85.
Sakumi K, Shiraishi A, Shimizu S, Tsuzuki T, Ishikawa T, Sekiguchi M. Methylnitrosourea-induced tumorigenesis in MGMT gene knockout mice. Cancer Res 1997; 57: 2415–8.
Iwakuma T, Sakumi K, Nakatsuru Y, et al. High incidence of nitrosamine-induced tumorigenesis in mice lacking DNA repair methyltransferase. Carcinogenesis 1997; 18: 1631–5.
Sekiguchi M, Nakabeppu Y. Adaptive response: induced synthesis of DNA repair enzymes by alkylating agents. Trends Genet 1987; 3: 51–5.
Coulondre C, Miller JH. Genetic studies of the lac repressor IV. Mutagenic specificity in the lacI gene of Escherichia coli. J Mol Biol 1977; 117: 577–606.
Sekiguchi M, Nakabeppu Y, Sakumi K, Tsuzuki T. DNA-repair methyltransferase as a molecular device for preventing mutation and cancer. J Cancer Res Clin Oncol 1996; 122: 199–206.
Ishibashi T, Nakabeppu Y, Sekiguchi M. Artificial control of nuclear translocation of DNA repair methyltransferase. J Biol Chem 1994; 269: 7645–50.
Mitra G, Pauly GT, Kumar R, et al. Molecular analysis of O6-substituted guanine-induced mutagenesis of ras oncogenes. Proc Natl Acad Sci U S A 1989; 86: 8650–4.
Challen C, Lunec J, Warren W, Collier J, Bassendine MF. Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain. Hepatology 1992; 16: 1362–6.
Esteller M, Toyota M, Sanchez-CM, et al. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res 2000; 60: 2368–71.
Hall J, Bresil H, Serres M, Martel PG, Wild CP, Montesano R. Modulation of O6-methylguanine-DNA methyltransferase in rat and hamster liver after treatment with dimethylnitrosamine. Cancer Res 1990; 50: 5426–30.
Nakatsuru Y, Matsukuma S, Nemoto N, Sugano H, Sekiguchi M, Ishikawa T. O6-Methylguanine-DNA methyltransferase protects against nitrosamine-induced hepatocarcinogenesis. Proc Natl Acad Sci U S A 1993; 90: 6468–72.
Nakatsuru Y, Matsukuma S, Sekiguchi M, Ishikawa T. Characterization of O6-methylguanine-DNA methyltransferase in transgenic mice introduced with the E.coli ada gene. Mutat Res 1991; 254: 225–30.
Tsuzuki T, Sakumi K, Shiraishi A, et al. Targeted disruption of the DNA repair methyltransferase gene renders mice hypersensitive to alkylating agent. Carcinogenesis 1996; 17: 1215–20.
Zaidi NH, Liu L, Gerson SL. Quantitative immunohistochemical estimates of O6-alkylguanine-DNA alkyltransferase expression in normal and malignant human colon. Clin Cancer Res 1996; 2: 577–84.
Sobin LH, Wittekind C. UICC TNM Classification of Malignant Tumors. 5th ed. Berlin: Springer, 1997.
Nakabeppu Y, Nathans D. A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity. Cell 1991; 64: 751–9.
Studier FW, Rosenberg AH, Dunn JJ. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol 1990; 185: 60–89.
Kawate H, Ihara K, Kohda K, Nakabeppu Y, Sekiguchi M. Mouse methyltransferase for repair of O6-methylguanine and O4-methylthymine. Carcinogenesis 1995; 16: 1595–602.
Belanich M, Randall T, Pastor MA, et al. Intracellular localization and intracellular heterogeneity of the human DNA repair protein O6-methylguanine-DNA methyltransferase. Cancer Chemother Pharmacol 1996; 37: 547–55.
Estellar M, Hamilton SR, Burger PC, Baylin SB, Herman JG. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 1999; 59: 793–7.
Ishibashi T, Nakabeppu Y, Kawate H, Sakumi K, Hayakawa H, Sekiguchi M. Intracellular localization and function of DNA repair methyltransferase in human cells. Mutat Res 1994; 315: 199–212.
Fritz G, Kaina B. Genomic differences between O6-methylguanine-DNA methyltransferase proficient (Mex+) and deficient (Mex−) cell lines: possible role of genetic and epigenetic changes in conversion of Mex+ into Mex−. Biochem Biophys Res Commun 1992; 183: 1184–90.
Kokkinakis DM, Ahmed MM, Delgado R, Fruitwala MM, Mohiuddin M, Albores SJ. Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents. Cancer Res 1997; 57: 360–8.
Major GN, Collier JD. Repair of DNA lesion O6-methylguanine in hepatocellular carcinogenesis. J Hepatobiliary Pancreat Surg 1998; 5: 355–66.
Wani G, D’Ambrosio SM. Expression of the O6-alkylguanine-DNA alkyltransferase gene is elevated in human breast tumor cells. Anticancer Res 1997; 17: 4311–6.
Pellegata NS, Sessa F, Renault B, et al. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res 1994; 54: 1556–60.
Luttges J, Schlehe B, Menke MA, Vogel I, Henne-Bruns D, Kloppel G. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, metaplastic ductal epithelium. Cancer 1999; 85: 1703–10.
Tortola S, Marcuello E, Gonzalez I, et al. p53 and K-ras gene mutations correlate with tumor aggressiveness but are not of routine prognostic value in colorectal cancer. J Clin Oncol 1999; 17: 1375–81.
Esteller M, Gonzalez S, Risques RA, et al. K-ras and p16 aberrations confer poor prognosis in human colorectal cancer. J Clin Oncol 2001; 19: 299–304.
Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759–67.
Wang L, Zhu D, Zhang C, et al. Mutations of O6-methylguanine-DNA methyltransferase gene in esophageal cancer tissues from Northern China. Int J Cancer 1997; 71: 719–23.
Otsuka M, Abe M, Nakabeppu Y, Sekiguchi M, Suzuki T. Polymorphism in the human O6-methylguanine-DNA methyltransferase gene detected by PCR-SSCP analysis. Pharmacogenetics 1996; 6: 361–3.
Inoue R, Abe M, Nakabeppu Y, Sekiguchi M, Mori T, Suzuki T. Characterization of human polymorphic DNA repair methyltransferase. Pharmacogenetics 2000; 10: 59–66.
Imai Y, Oda H, Nakatsuru Y, Ishikawa T. A polymorphism at codon 160 of human O6-methylguanine-DNA methyltransferase gene in young patients with adult cancers and functional assay. Carcinogenesis 1995; 16: 2441–5.
Rusin M, Samojedny A, Harris CC, Chorazy M. O6-methylguanine-DNA methyltransferase (MGMT) and N-methylpurine-DNA glycosylase (MPG) in lung cancer patients from Poland. Hum Mutat 1999; 14: 269–70.
Danam RP, Qian XC, Howell SR, Brent TP. Methylation of selected CpGs in the human O6-methylguanine-DNA methyltransferase promoter region as a marker of gene silencing. Mol Carcinogenog 1999; 24: 85–9.
HerfarthKK-F, Brent TP, Danam RP, et al. A specific CpG methylation pattern of the MGMT promoter region associated with reduced MGMT expression in primary colorectal cancers. Mol Carcinogenog 1999; 24: 90–8.
Stirzaker C, Millar DS, Paul CL, et al. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res 1997; 57: 2229–37.
Hermann JG, Merlo A, Mao L, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995; 55: 4525–30.
Gonzalez ZM, Bender CM, Yang AS, et al. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 1995; 55: 4531–5.
Archey WB, Sweet MP, Alig GC, Arrick BA. Methylation of CpG as a determinant of transcriptional activation at alternative promoters for transforming growth factor-β3. Cancer Res 1999; 59: 2292–6.
Graff JR, Hermann JG, Lapidus RG, et al. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 1995; 55: 5195–9.
Hiraguri S, Godfrey T, Nakamura H, et al. Mechanism of inactivation of E-cadherin in breast cancer cell lines. Cancer Res 1998; 58: 1972–7.
Lou W, Krill D, Dhir R, et al. Methylation of the CD44 metastasis suppressor gene in human prostate cancer. Cancer Res 1999; 59: 2329–31.
Corn PG, Kuerbitz SJ, Noesel MM, et al. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt’s lymphoma is associated with 5′ CpG island methylation. Cancer Res 1999; 59: 3352–6.
Cunningham JM, Christensen ER, Tester DJ, et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 1998; 58: 3455–60.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matsukura, S., Miyazaki, K., Yakushiji, H. et al. Expression and Prognostic Significance ofO 6-Methylguanine-DNA Methyltransferase in Hepatocellular, Gastric, and Breast Cancers. Ann Surg Oncol 8, 807–816 (2001). https://doi.org/10.1007/s10434-001-0807-9
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10434-001-0807-9